Volume Stonkers | NVIDIA rose 2.63%, Morgan Stanley Recommends Buying Before Earnings Season Ends

NVIDIA, ranked first by trading volume, rose 2.63%, with a trading volume of $26.895 billion. Morgan Stanley maintained its buy rating on NVIDIA and recommended purchasing before the end of the earnings season. Additionally, the application of DeepSeek technology offers potential benefits to NVIDIA.

Tesla, in second place, fell 0.03%, with a trading volume of $24.127 billion. Tesla posted job openings around Mumbai, India, on LinkedIn, indicating its expansion plans in the Indian market. Additionally, a U.S. court dismissed Tesla's request to block competitors from selling dry-cell electrode solutions.

Meta, in third place, rose 1.11%, with a trading volume of $12.422 billion. Meta introduced a new pre-training framework, reducing training tokens by 21.5%, and was fully divested by Dutch pension fund ABP.

Apple, in fourth place, rose 1.27%, with a trading volume of $9.976 billion. Goldman Sachs noted that Apple's shipment growth in China improved in December, with a positive sales outlook for the first quarter.

Microsoft, in fifth place, fell 0.51%, with a trading volume of $9.276 billion. Microsoft open-sourced an innovation framework that can transform DeepSeek into an AI Agent and launched a certified artificial intelligence engineer program.

Palantir, in sixth place, rose 1.06%, with a trading volume of $7.784 billion. Large pension funds purchased Palantir shares, indicating confidence in its future development.

Alibaba, in seventh place, rose 4.34%, with a trading volume of $6.540 billion. Alibaba's "AI+ business" has surged, with a year-to-date increase of over 47%, becoming a market focal point.

SMCI, in eighth place, rose 13.32%, with a trading volume of $6.219 billion. SMCI's performance guidance exceeded expectations, becoming a hot topic in the market.

Amazon, in ninth place, fell 0.73%, with a trading volume of $6.179 billion. Amazon updated questions in its machine learning engineer interview preparation course, highlighting its focus on talent development.

Applovin, in tenth place, rose 8.15%, with a trading volume of $5.637 billion. Wall Street analysts raised Applovin's target price, but warnings have also emerged.

Intel, in eleventh place, fell 2.20%, with a trading volume of $5.457 billion. Rumors suggest TSMC plans to acquire a 20% stake in Intel's wafer plant, drawing market attention to Intel's equity dynamics.

Coinbase Global, in twelfth place, fell 7.98%, with a trading volume of $5.384 billion. Coinbase continues to expand in the cryptocurrency market, impacting Robinhood's market share.

TSMC, in thirteenth place, rose 1.03%, with a trading volume of $4.674 billion. TSMC is reportedly in preliminary talks with Broadcom, considering a split with Intel.

Microstrategy, in fourteenth place, rose 3.94%, with a trading volume of $4.660 billion. Microstrategy's strategic preferred shares outperformed peers by 19% over the past two weeks, significantly enhancing liquidity.

Broadcom, in fifteenth place, fell 1.17%, with a trading volume of $3.957 billion. Broadcom's strategic acquisitions and position in the AI chip market have bolstered its buy rating.

Google A, in sixteenth place, fell 0.49%, with a trading volume of $3.788 billion. Google was fully divested by Dutch pension fund ABP, indicating market caution about its prospects.

Advanced Micro Devices, in seventeenth place, rose 1.15%, with a trading volume of $3.675 billion. AMD plans to launch new products at an upcoming event, demonstrating its commitment to technological innovation.

Airbnb, in eighteenth place, rose 14.45%, with a trading volume of $3.483 billion. Goldman Sachs raised Airbnb's target price, reflecting market optimism about its future growth potential.

Netflix, in nineteenth place, rose 1.43%, with a trading volume of $3.314 billion. Netflix clarified that its presence on Apple TV was a system error and not an expansion of related features.

Eli Lilly, in twentieth place, fell 3.00%, with a trading volume of $2.749 billion. DBS Bank maintained its buy rating on Eli Lilly, indicating confidence in its long-term development prospects.